Articles
In APAC, the biosimilar market is set to grow

In APAC, the biosimilar market is set to grow

Syamala Ariyanchira shares her opinions on the growth opportunities in the biosimilar market within emerging markets, with a particular focus on China, India and Korea. The market sentiments towards biosimilars vary widely between the regulated and the semi- and unregulated markets. While regulated markets adopt...

Articles
Drug shortage strategies

Drug shortage strategies

Darshan Kulkarni highlights the problems associated with drug shortages in healthcare. This is intended to be a discussion of how healthcare providers are dealing with drug shortages. This blog will give a front line view...

Articles
Pharma gets social: China – pharma’s social media frontier

Pharma gets social: China – pharma’s social media frontier

In this month’s ‘Pharma gets social’ article, Daniel Ghinn explores the digital and social media channels in China, to coincide with our emerging markets focus. While social media is still considered by some in pharmaceutical marketing to be a new frontier anywhere in the world, the emerging market of China...

Sales & Marketing

Digital

Market Access

Editor's Picks

  1. ESMO26: Tango sees 82% ORR with combo in pancreatic cancer
  2. Roche offers $15bn for strategic-level deal with Hansoh
  3. ESMO26: Moderna, MSD reveal cancer jab data early after leak
  4. Clinical trial setup times fall sharply in UK
  5. Despite US policy changes, drug prices stay stubbornly high

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more